Jonathan B. Perlin, Pres-Clinical Services & CMO at HCA Holdings, Inc. (HCA), sold 32,010 shares at $89.00 ($2.8M) on 2015-06-25, disclosed to the SEC on 2015-06-29.
Scheduled sale ($2.8M) by Pres-Clinical Services & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.00 | 18,005 | $1.5M | 55.4% |
| 2 | $89.00 | 14,005 | $1.2M | 44.6% |
| Total | $87.31 avg | 32,010 | $2.8M | 100% |
| Filing → |
| HCA | SELL | 2020-11-17 | $2.5M | — | Filing → |
| HCA | SELL | 2020-11-09 | $1.6M | — | Filing → |
| HCA | SELL | 2018-07-27 | $18.8M | — | Filing → |